Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 948

1.

Imaging Features Associated With Failure of Nonoperative Management of Intraabdominal Abscesses in Crohn Disease.

Perl D, Waljee AK, Bishu S, Higgins PDR, Wasnik AP, Stidham RW.

Inflamm Bowel Dis. 2019 Apr 25. pii: izz069. doi: 10.1093/ibd/izz069. [Epub ahead of print]

PMID:
31294779
2.

TGF-β1-p53 cooperativity regulates a profibrotic genomic program in the kidney: molecular mechanisms and clinical implications.

Higgins CE, Tang J, Mian BM, Higgins SP, Gifford CC, Conti DJ, Meldrum KK, Samarakoon R, Higgins PJ.

FASEB J. 2019 Jul 6:fj201900943R. doi: 10.1096/fj.201900943R. [Epub ahead of print]

PMID:
31284746
3.

Challenges in the Pathophysiology, Diagnosis and Management of Intestinal Fibrosis in Inflammatory Bowel Disease.

D'Haens G, Rieder F, Feagan BG, Higgins PDR, Panes J, Maaser C, Rogler G, Löwenberg M, van der Voort R, Pinzani M, Peyrin-Biroulet L, Danese S; IOIBD Fibrosis Working Group.

Gastroenterology. 2019 Jun 26. pii: S0016-5085(19)41035-4. doi: 10.1053/j.gastro.2019.05.072. [Epub ahead of print]

PMID:
31254502
4.

Controlling intestinal colonization of high-risk haematology patients with ESBL-producing Enterobacteriaceae: a randomized, placebo-controlled, multicentre, Phase II trial (CLEAR).

Dimitriou V, Biehl LM, Hamprecht A, Vogel W, Dörfel D, Peter S, Schafhausen P, Rohde H, von Lilienfeld-Toal M, Klassert TE, Slickers P, Ehricht R, Slevogt H, Christ H, Hellmich M, Farowski F, Tsakmaklis A, Higgins PG, Seifert H, Vehreschild MJGT.

J Antimicrob Chemother. 2019 Jul 1;74(7):2065-2074. doi: 10.1093/jac/dkz124.

PMID:
31220256
5.

The adequacy of lymph node clearance in colon cancer surgery performed in a non-specialist centre; implications for practice.

Higgins P, Nemeth T, Bennani F, Khan W, Khan I, Waldron R, Barry K.

Ir J Med Sci. 2019 Jun 19. doi: 10.1007/s11845-019-02044-1. [Epub ahead of print]

PMID:
31218518
6.

Generation and selection of antibodies for a novel immunochromatographic lateral flow test to rapidly identify OXA-23-like-mediated carbapenem resistance in Acinetobacter baumannii.

Mertins S, Higgins PG, Rodríguez MG, Borlon C, Gilleman Q, Mertens P, Seifert H, Krönke M, Klimka A.

J Med Microbiol. 2019 Jul;68(7):1021-1032. doi: 10.1099/jmm.0.001015. Epub 2019 Jun 12.

PMID:
31188094
7.

In vitro activity of mecillinam and nitroxoline against Neisseria gonorrhoeae - re-purposing old antibiotics in the multi-drug resistance era.

Fuchs F, Wille J, Hamprecht A, Parcina M, Lehmann C, Schwarze-Zander C, Seifert H, Higgins PG.

J Med Microbiol. 2019 Jul;68(7):991-995. doi: 10.1099/jmm.0.001014. Epub 2019 Jun 4.

PMID:
31162022
8.

Characterizing intestinal strictures of Crohn's disease in vivo by endoscopic photoacoustic imaging.

Lei H, Johnson LA, Eaton KA, Liu S, Ni J, Wang X, Higgins PDR, Xu G.

Biomed Opt Express. 2019 Apr 24;10(5):2542-2555. doi: 10.1364/BOE.10.002542. eCollection 2019 May 1.

9.

Performance of a Deep Learning Model vs Human Reviewers in Grading Endoscopic Disease Severity of Patients With Ulcerative Colitis.

Stidham RW, Liu W, Bishu S, Rice MD, Higgins PDR, Zhu J, Nallamothu BK, Waljee AK.

JAMA Netw Open. 2019 May 3;2(5):e193963. doi: 10.1001/jamanetworkopen.2019.3963.

10.

Rac-GTPase promotes fibrotic TGF-β1 signaling and chronic kidney disease via EGFR, p53, and Hippo/YAP/TAZ pathways.

Patel S, Tang J, Overstreet JM, Anorga S, Lian F, Arnouk A, Goldschmeding R, Higgins PJ, Samarakoon R.

FASEB J. 2019 May 16:fj201802489RR. doi: 10.1096/fj.201802489RR. [Epub ahead of print]

PMID:
31095421
11.

Role of nerve block as a diagnostic tool in pudendal nerve entrapment.

Dickson E, Higgins P, Sehgal R, Gorissen K, Jones O, Cunningham C, Hogan AM, Lindsey I.

ANZ J Surg. 2019 Jun;89(6):695-699. doi: 10.1111/ans.15275. Epub 2019 May 15.

PMID:
31090184
12.

Development and Validation of Machine Learning Models in Prediction of Remission in Patients With Moderate to Severe Crohn Disease.

Waljee AK, Wallace BI, Cohen-Mekelburg S, Liu Y, Liu B, Sauder K, Stidham RW, Zhu J, Higgins PDR.

JAMA Netw Open. 2019 May 3;2(5):e193721. doi: 10.1001/jamanetworkopen.2019.3721. Erratum in: JAMA Netw Open. 2019 Jun 5;2(6):e197386.

13.

Citrobacter rodentium Induces Tissue-Resident Memory CD4+ T Cells.

Bishu S, Hou G, El Zaatari M, Bishu SR, Popke D, Zhang M, Grasberger H, Zou W, Stidham RW, Higgins PDR, Spence JR, Kamada N, Kao JY.

Infect Immun. 2019 Jun 20;87(7). pii: e00295-19. doi: 10.1128/IAI.00295-19. Print 2019 Jul.

PMID:
31061145
14.

Electronic Neurostatus-EDSS increases the quality of expanded disability status scale assessments: Experience from two phase 3 clinical trials.

D'Souza M, Heikkilä A, Lorscheider J, Haller V, Kravalis K, Gysin S, Fuertes NAC, Fricker E, Lam E, Higgins P, Tomic D, Papadopoulou A, Kappos L.

Mult Scler. 2019 May 7:1352458519845108. doi: 10.1177/1352458519845108. [Epub ahead of print]

PMID:
31060429
15.

Serum Protein Biomarkers of Fibrosis Aid in Risk Stratification of Future Stricturing Complications in Pediatric Crohn's Disease.

Wu J, Lubman DM, Kugathasan S, Denson LA, Hyams JS, Dubinsky MC, Griffiths AM, Baldassano RN, Noe JD, Rabizadeh S, Gulati AS, Rosh JR, Crandall WV, Higgins PDR, Stidham RW.

Am J Gastroenterol. 2019 May;114(5):777-785. doi: 10.14309/ajg.0000000000000237.

PMID:
31058681
16.

Phenotypic and Genotypic Characterization of Acinetobacter spp. Panel Strains: A Cornerstone to Facilitate Antimicrobial Development.

D'Souza R, Pinto NA, Phuong NL, Higgins PG, Vu TN, Byun JH, Cho YL, Choi JR, Yong D.

Front Microbiol. 2019 Mar 26;10:559. doi: 10.3389/fmicb.2019.00559. eCollection 2019.

17.

Acinetobacter baumannii analysis by core genome multi-locus sequence typing in two hospitals in Bolivia: endemicity of international clone 7 isolates (CC25).

Cerezales M, Xanthopoulou K, Wille J, Bustamante Z, Seifert H, Gallego L, Higgins PG.

Int J Antimicrob Agents. 2019 Jun;53(6):844-849. doi: 10.1016/j.ijantimicag.2019.03.019. Epub 2019 Mar 27.

PMID:
30928684
18.

Efficacy of Fecal Microbiota Transplantation in Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis.

Xu D, Chen VL, Steiner CA, Berinstein JA, Eswaran S, Waljee AK, Higgins PDR, Owyang C.

Am J Gastroenterol. 2019 Jul;114(7):1043-1050. doi: 10.14309/ajg.0000000000000198.

PMID:
30908299
19.

The Impact of Raising the Bar for Clinical Trials in Ulcerative Colitis.

Sands BE, Cheifetz AS, Nduaka CI, Quirk D, Wang W, Maller E, Friedman GS, Su C, Higgins PDR.

J Crohns Colitis. 2019 Feb 14. pii: jjz038. doi: 10.1093/ecco-jcc/jjz038. [Epub ahead of print]

PMID:
30879034
20.

Seasonal Occurrence and Carbapenem Susceptibility of Bovine Acinetobacter baumannii in Germany.

Klotz P, Higgins PG, Schaubmar AR, Failing K, Leidner U, Seifert H, Scheufen S, Semmler T, Ewers C.

Front Microbiol. 2019 Feb 22;10:272. doi: 10.3389/fmicb.2019.00272. eCollection 2019.

21.

Multi-state study of Enterobacteriaceae harboring extended-spectrum beta-lactamase and carbapenemase genes in U.S. drinking water.

Tanner WD, VanDerslice JA, Goel RK, Leecaster MK, Fisher MA, Olstadt J, Gurley CM, Morris AG, Seely KA, Chapman L, Korando M, Shabazz KA, Stadsholt A, VanDeVelde J, Braun-Howland E, Minihane C, Higgins PJ, Deras M, Jaber O, Jette D, Gundlapalli AV.

Sci Rep. 2019 Mar 8;9(1):3938. doi: 10.1038/s41598-019-40420-0.

22.

Identification of the novel class D β-lactamase OXA-679 involved in carbapenem resistance in Acinetobacter calcoaceticus.

Tietgen M, Kramer JS, Brunst S, Djahanschiri B, Wohra S, Higgins PG, Weidensdorfer M, Riedel-Christ S, Pos KM, Gonzaga A, Steglich M, Nübel U, Ebersberger I, Proschak E, Göttig S.

J Antimicrob Chemother. 2019 Jun 1;74(6):1494-1502. doi: 10.1093/jac/dkz080.

PMID:
30844059
23.

Potential biomarkers to predict outcome of faecal microbiota transfer for recurrent Clostridioides difficile infection.

Farowski F, Solbach P, Tsakmaklis A, Brodesser S, Cruz Aguilar MR, Cornely OA, Dettmer K, Higgins PG, Suerbaum S, Jazmati N, Oefner PJ, Vehreschild MJGT; German Clinical Microbiome Study Group (GCMSG).

Dig Liver Dis. 2019 Jul;51(7):944-951. doi: 10.1016/j.dld.2019.01.012. Epub 2019 Jan 26.

PMID:
30770201
24.

Flagellin-mediated activation of IL-33-ST2 signaling by a pathobiont promotes intestinal fibrosis.

Imai J, Kitamoto S, Sugihara K, Nagao-Kitamoto H, Hayashi A, Morhardt TL, Kuffa P, Higgins PDR, Barnich N, Kamada N.

Mucosal Immunol. 2019 May;12(3):632-643. doi: 10.1038/s41385-019-0138-4. Epub 2019 Feb 11.

PMID:
30742042
25.

Epidemiological Typing of Serratia marcescens Isolates by Whole-Genome Multilocus Sequence Typing.

Rossen JWA, Dombrecht J, Vanfleteren D, De Bruyne K, van Belkum A, Rosema S, Lokate M, Bathoorn E, Reuter S, Grundmann H, Ertel J, Higgins PG, Seifert H.

J Clin Microbiol. 2019 Mar 28;57(4). pii: e01652-18. doi: 10.1128/JCM.01652-18. Print 2019 Apr.

PMID:
30728192
26.

CD4+ tissue-resident memory T-cells expand and are a major source of mucosal tumor necrosis factor α in active Crohn's Disease.

Bishu S, El Zaatari M, Hayashi A, Hou G, Bowers N, Kinnucan J, Manoogian B, Muza-Moons MM, Zhang M, Grasberger H, Bourque C, Zou W, Higgins PDR, Spence JR, Stidham RW, Kamada N, Kao JY.

J Crohns Colitis. 2019 Feb 4. doi: 10.1093/ecco-jcc/jjz010. [Epub ahead of print]

PMID:
30715262
27.

Duodenal adipose tissue is associated with obesity in baboons (Papio sp): a novel site of ectopic fat deposition in non-human primates.

Higgins PB, Folli F, Andrade MCR, Foster J, Mattern V, Paroni R, Schlabritz-Loutsevitch N, Voruganti VS, Kumar S, Guardado-Mendoza R, Bulfamante G, Fiorina P, Pontiroli AE, Hubbard GB, Owston M, Dick EJ Jr, Comuzzie AG.

Acta Diabetol. 2019 Feb;56(2):227-236. doi: 10.1007/s00592-019-01286-w. Epub 2019 Jan 23.

28.

Long-term safety and tolerability of oral tofacitinib in patients with Crohn's disease: results from a phase 2, open-label, 48-week extension study.

Panés J, D'Haens GR, Higgins PDR, Mele L, Moscariello M, Chan G, Wang W, Niezychowski W, Su C, Maller E.

Aliment Pharmacol Ther. 2019 Feb;49(3):265-276. doi: 10.1111/apt.15072.

PMID:
30663107
29.

Impact of single-room contact precautions on hospital-acquisition and transmission of multidrug-resistant Escherichia coli: a prospective multicentre cohort study in haematological and oncological wards.

Biehl LM, Higgins P, Wille T, Peter K, Hamprecht A, Peter S, Dörfel D, Vogel W, Häfner H, Lemmen S, Panse J, Rohde H, Klupp EM, Schafhausen P, Imirzalioglu C, Falgenhauer L, Salmanton-García J, Stecher M, Vehreschild JJ, Seifert H, Vehreschild MJGT.

Clin Microbiol Infect. 2019 Aug;25(8):1013-1020. doi: 10.1016/j.cmi.2018.12.029. Epub 2019 Jan 12.

PMID:
30641228
30.

Investigation of Novel pmrB and eptA Mutations in Isogenic Acinetobacter baumannii Isolates Associated with Colistin Resistance and Increased Virulence In Vivo.

Gerson S, Betts JW, Lucaßen K, Nodari CS, Wille J, Josten M, Göttig S, Nowak J, Stefanik D, Roca I, Vila J, Cisneros JM, La Ragione RM, Seifert H, Higgins PG.

Antimicrob Agents Chemother. 2019 Feb 26;63(3). pii: e01586-18. doi: 10.1128/AAC.01586-18. Print 2019 Mar.

PMID:
30617096
31.

Adalimumab persistence for inflammatory bowel disease in veteran and insured cohorts.

Govani SM, Lipson R, Noureldin M, Wiitala W, Higgins PDR, Saini SD, Pugh JA, Velligan DI, Stidham RW, Waljee AK.

Am J Manag Care. 2018 Dec 1;24(12):e374-e379.

32.

Characterization of Brain Signatures to Add Precision to Self-Management Health Information Interventions.

Moore SM, Musil CM, Jack AI, Alder ML, Fresco DM, Webel A, Wright KD, Sattar A, Higgins P.

Nurs Res. 2019 Mar/Apr;68(2):127-134. doi: 10.1097/NNR.0000000000000331.

PMID:
30540702
33.

The Development of Patient-Reported Outcome Measures in Inflammatory Bowel Disease.

Higgins PDR.

Gastroenterol Hepatol (N Y). 2018 Nov;14(11):658-661. No abstract available.

34.

Efficacy of Induction Therapy With High-Intensity Tofacitinib in 4 Patients With Acute Severe Ulcerative Colitis.

Berinstein JA, Steiner CA, Regal RE, Allen JI, Kinnucan JAR, Stidham RW, Waljee AK, Bishu S, Aldrich LB, Higgins PDR.

Clin Gastroenterol Hepatol. 2019 Apr;17(5):988-990.e1. doi: 10.1016/j.cgh.2018.11.022. Epub 2018 Nov 17.

PMID:
30458248
35.

Incidence and predictors of new persistent opioid use following inflammatory bowel disease flares treated with oral corticosteroids.

Noureldin M, Higgins PDR, Govani SM, Cohen-Mekelburg S, Kenney BC, Stidham RW, Waljee JF, Waljee AK.

Aliment Pharmacol Ther. 2019 Jan;49(1):74-83. doi: 10.1111/apt.15023. Epub 2018 Nov 14.

PMID:
30430615
36.

Molecular biomarkers of Graves' ophthalmopathy.

Longo CM, Higgins PJ.

Exp Mol Pathol. 2019 Feb;106:1-6. doi: 10.1016/j.yexmp.2018.11.004. Epub 2018 Nov 8. Review.

PMID:
30414981
37.

Critical Appraisal of Programmed Death Ligand 1 Reflex Diagnostic Testing: Current Standards and Future Opportunities.

Humphries MP, McQuaid S, Craig SG, Bingham V, Maxwell P, Maurya M, McLean F, Sampson J, Higgins P, Greene C, James J, Salto-Tellez M.

J Thorac Oncol. 2019 Jan;14(1):45-53. doi: 10.1016/j.jtho.2018.09.025. Epub 2018 Oct 6.

38.

Assessment of urinary 3-indoxyl sulfate as a marker for gut microbiota diversity and abundance of Clostridiales.

Farowski F, Els G, Tsakmaklis A, Higgins PG, Kahlert CR, Stein-Thoeringer CK, Bobardt JS, Dettmer-Wilde K, Oefner PJ, Vehreschild JJ, Vehreschild MJGT.

Gut Microbes. 2019;10(2):133-141. doi: 10.1080/19490976.2018.1502536. Epub 2018 Aug 17.

PMID:
30118620
39.

A Method for Cryogenic Preservation of Human Biopsy Specimens and Subsequent Organoid Culture.

Tsai YH, Czerwinski M, Wu A, Dame MK, Attili D, Hill E, Colacino JA, Nowacki LM, Shroyer NF, Higgins PDR, Kao JY, Spence JR.

Cell Mol Gastroenterol Hepatol. 2018 May 30;6(2):218-222.e7. doi: 10.1016/j.jcmgh.2018.04.008. eCollection 2018. No abstract available.

40.

Papio spp. Colon microbiome and its link to obesity in pregnancy.

Li X, Rensing C, Taylor WL, Costelle C, Brejnrod AD, Ferry RJ Jr, Higgins PB, Folli F, Kottapalli KR, Hubbard GB, Dick EJ Jr, Yooseph S, Nelson KE, Schlabritz-Loutsevitch N.

J Med Primatol. 2018 Dec;47(6):393-401. doi: 10.1111/jmp.12366. Epub 2018 Jul 24.

PMID:
30039863
41.

5-ASA to sulfasalazine drug switch program in patients with ulcerative colitis.

Goldsmith JR, Waljee AK, George T, Brown A, Choe HM, Noureldin M, Bernstein SJ, Higgins PDR.

Am J Manag Care. 2018 Jul;24(8 Spec No.):SP303-SP308.

42.

Tofacitinib Induction Therapy Reduces Symptoms Within 3 Days for Patients With Ulcerative Colitis.

Hanauer S, Panaccione R, Danese S, Cheifetz A, Reinisch W, Higgins PDR, Woodworth DA, Zhang H, Friedman GS, Lawendy N, Quirk D, Nduaka CI, Su C.

Clin Gastroenterol Hepatol. 2019 Jan;17(1):139-147. doi: 10.1016/j.cgh.2018.07.009. Epub 2018 Sep 10.

43.

Methotrexate Is Not Superior to Placebo in Maintaining Steroid-Free Response or Remission in Ulcerative Colitis.

Herfarth H, Barnes EL, Valentine JF, Hanson J, Higgins PDR, Isaacs KL, Jackson S, Osterman MT, Anton K, Ivanova A, Long MD, Martin C, Sandler RS, Abraham B, Cross RK, Dryden G, Fischer M, Harlan W, Levy C, McCabe R, Polyak S, Saha S, Williams E, Yajnik V, Serrano J, Sands BE, Lewis JD; Clinical Research Alliance of the Crohn’s and Colitis Foundation.

Gastroenterology. 2018 Oct;155(4):1098-1108.e9. doi: 10.1053/j.gastro.2018.06.046. Epub 2018 Jun 30.

PMID:
29964043
44.

One health in our backyard: Design and evaluation of an experiential learning experience for veterinary medical students.

Mor SM, Norris JM, Bosward KL, Toribio JLML, Ward MP, Gongora J, Vost M, Higgins PC, McGreevy PD, White PJ, Zaki S.

One Health. 2018 May 2;5:57-64. doi: 10.1016/j.onehlt.2018.05.001. eCollection 2018 Jun.

45.

Deregulation of Negative Controls on TGF-β1 Signaling in Tumor Progression.

Tang J, Gifford CC, Samarakoon R, Higgins PJ.

Cancers (Basel). 2018 May 25;10(6). pii: E159. doi: 10.3390/cancers10060159. Review.

46.

An Observational Cohort Study of Clostridium difficile Ribotype 027 and Recurrent Infection.

Rao K, Higgins PDR, Young VB.

mSphere. 2018 May 23;3(3). pii: e00033-18. doi: 10.1128/mSphere.00033-18. eCollection 2018 May-Jun.

47.

Correction: Corticosteroid Use and Complications in a US Inflammatory Bowel Disease Cohort.

Waljee AK, Wiitala WL, Govani S, Stidham R, Saini S, Hou J, Feagins LA, Khan N, Good CB, Vijan S, Higgins PDR.

PLoS One. 2018 May 9;13(5):e0197341. doi: 10.1371/journal.pone.0197341. eCollection 2018.

48.

Identification of Acinetobacter seifertii isolated from Bolivian hospitals.

Cerezales M, Xanthopoulou K, Ertel J, Nemec A, Bustamante Z, Seifert H, Gallego L, Higgins PG.

J Med Microbiol. 2018 Jun;67(6):834-837. doi: 10.1099/jmm.0.000751. Epub 2018 May 8.

PMID:
29737964
49.

Production-phase greenhouse gas emissions arising from deliberate withdrawal and destruction of fresh fruit and vegetables under the EU's Common Agricultural Policy.

Porter SD, Reay DS, Bomberg E, Higgins P.

Sci Total Environ. 2018 Aug 1;631-632:1544-1552. doi: 10.1016/j.scitotenv.2018.03.089. Epub 2018 Mar 28.

PMID:
29727978
50.

Characterization of Acinetobacter baumannii from water and sludge line of secondary wastewater treatment plant.

Higgins PG, Hrenovic J, Seifert H, Dekic S.

Water Res. 2018 Sep 1;140:261-267. doi: 10.1016/j.watres.2018.04.057. Epub 2018 Apr 26.

PMID:
29723815

Supplemental Content

Loading ...
Support Center